SARS-CoV binding can downregulate ACE2 expression, resulting in endothelial dysfunction.[52] Interestingly, recombinant angiotensin-converting enzyme 2 blocks SARS-CoV-2 to infect engineered human vascular ECs.[53]. The gene discussed is ACE2; the disease is endothelial dysfunction.